Pralsetinib is an advanced FDA approved medication known for its efficacy in the management of NSCLC. The specific indication is for adult patients with metastatic RET fusion-positive non-small cell lung…
Pralsetinib is an advanced FDA approved medication known for its efficacy in the management of NSCLC. The specific indication is for adult patients with metastatic RET fusion-positive non-small cell lung…